Calithera Biosciences, Inc.
Records under this name other than the patents Calithera Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Calithera Biosciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,345,706 | Benzoxazole Kinase Inhibitors and Methods of Use Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,181,255 | Fused Heteroaromatic Pyrrolidinones as Syk Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 9,108,970 | Fused Heteroaromatic Pyrrolidinones Formerly held In force · High confidence | In force | High confidence | |
| US 8,476,282 | Benzoxazole kinase inhibitors and methods of use Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,476,431 | Benzoxazole Kinase Inhibitors and Methods of Use Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,440,689 | Fused Heteroaromatic Pyrrolidinones Formerly held In force · High confidence | In force | High confidence | |
| US 8,604,016 | Heterocyclic inhibitors of glutaminase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,865,718 | Heterocyclic inhibitors of glutaminase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,938,267 | Heterocyclic inhibitors of glutaminase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,174,994 | Enhanced Treatment Regimens Using Mtor Inhibitors Formerly held In force · High confidence | In force | High confidence |